May 29, 2026 07:00AM
May 15, 2026 06:01AM
Apr 15, 2026 06:06AM
Apr 9, 2026 06:55AM
Mar 27, 2026 09:49AM
Mar 10, 2026 06:22AM
Mar 9, 2026 08:01AM William Blair Reiterates Outperform Rating on ARS Pharmaceuticals Inc (SPRY) following Q4 results
Mar 2, 2026 06:37AM
Dec 29, 2025 08:00AM
Nov 10, 2025 07:29AM
Nov 10, 2025 07:28AM
Nov 10, 2025 06:09AM
Nov 4, 2025 07:58AM
Oct 8, 2025 08:00AM ARS Pharmaceuticals wins European patent challenge for neffy spray
Sep 29, 2025 04:06PM
Sep 26, 2025 09:31AM
Sep 19, 2025 08:01AM
Sep 4, 2025 09:27AM
Aug 14, 2025 05:50AM
Aug 13, 2025 07:09AM
Jul 18, 2025 09:26AM U.K. approves ARS Pharmaceuticals' needle-free epinephrine nasal spray
Jun 30, 2025 06:02AM
May 14, 2025 04:13PM
May 14, 2025 10:22AM
Mar 31, 2025 06:19AM
Mar 24, 2025 05:24AM
Mar 20, 2025 10:06AM
Mar 7, 2025 07:07AM Scotiabank Starts ARS Pharmaceuticals Inc (SPRY) at Sector Outperform
Mar 5, 2025 04:11PM
Jan 6, 2025 08:10AM
Dec 12, 2024 02:33PM
Nov 11, 2024 07:03AM
Sep 23, 2024 08:12AM
Sep 9, 2024 04:47PM
Aug 26, 2024 09:31AM ARS Pharmaceuticals (SPRY): EURneffy Approved in EU as First and Only Needle-Free Emergency Treatment of Allergic Reactions
Aug 19, 2024 11:44PM
Aug 9, 2024 12:50PM
Aug 7, 2024 04:55AM
Jun 28, 2024 06:30AM

397,232 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All